Kristina Wallenius
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Pancreatic function and diabetes, Growth Hormone and Insulin-like Growth Factors, Adipose Tissue and Metabolism, Fibroblast Growth Factor Research
Most-Cited Works
- → Interleukin-6-deficient mice develop mature-onset obesity(2002)1,207 cited
- → Intracerebroventricular interleukin-6 treatment decreases body fat in rats(2002)237 cited
- → Interleukin-6 Levels in the Central Nervous System Are Negatively Correlated with Fat Mass in Overweight/Obese Subjects(2003)147 cited
- → Reduced Exercise Endurance in Interleukin-6-Deficient Mice(2004)141 cited
- → Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism(2001)138 cited
- → Effects of Liver-Derived Insulin-Like Growth Factor I on Bone Metabolism in Mice(2002)97 cited
- → Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice(2001)82 cited
- → Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis(2021)72 cited
- → The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis(2022)65 cited
- → Involvement of the metabolic sensor GPR81 in cardiovascular control(2017)57 cited